Company Filing History:
Years Active: 2018-2020
Title: Innovations by Yuanpeng Jin: Pioneering Advances in Pharmacology
Introduction: Yuanpeng Jin is an accomplished inventor based in Tianjin, China, with a focus on groundbreaking developments in the medical field. With two notable patents to his name, he has been instrumental in creating innovative solutions aimed at improving health and treating various conditions.
Latest Patents: Yuanpeng Jin’s latest patents include the "Salvianolic Acid Compound T, Preparation Method Therefor, and Use Thereof," which involves a unique salvage approach to pharmaceutical compositions and antioxidants. This invention not only identifies the structural formula of the compound but also elaborates on its potential uses, highlighting its role as a free radical scavenger. The second patent, "Substituted Cinnamamide Derivative, Preparation Method and Use Thereof," presents a method for preparing substituted cinnamamide derivatives that can be utilized in combating depressive-type mental diseases. The synthesis of these derivatives employs methods such as the Wittig reaction and acid-amine condensation reaction.
Career Highlights: Yuanpeng Jin works at Tasly Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical sector known for its commitment to research and health innovation. His contributions through patents showcase his dedication to advancing medical treatments and improving quality of life.
Collaborations: Throughout his career, Yuanpeng Jin has collaborated with esteemed coworkers, including Shuiping Zhou and Xiaohui Ma. These collaborations enhance his research capabilities, enabling him to push the boundaries of what is possible in pharmacological applications.
Conclusion: Yuanpeng Jin stands out as a notable inventor in the field of pharmaceuticals, his work advancing vital innovations that may transform how certain medical conditions are treated. With his patents underscoring significant findings in medical research, he plays a crucial role in paving the way for future advancements in health care.